학술논문

1625P Cyclin-dependent kinase 4/6 inhibitors (CDKI)-associated venous thromboembolism in patients with hormone receptor (HR)-positive breast cancer
Document Type
Abstract
Source
In Annals of Oncology September 2022 33 Supplement 7:S1284-S1284
Subject
Language
ISSN
0923-7534